Paris, France

Tabassome Simon

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Tabassome Simon: A Pioneer in Patient Prognosis

Introduction: Tabassome Simon, based in Paris, France, is an esteemed inventor recognized for his significant contributions to medical innovation. With a focus on improving patient outcomes, Simon has made strides in the field of cardiology through his impactful invention that directly addresses the challenges faced by myocardial infarction patients.

Latest Patents: Simon holds a notable patent for a method to predict survival time in patients suffering from myocardial infarction by measuring BAFF levels. The present invention outlines a systematic approach consisting of three key steps: determining the expression level of BAFF in patient samples, comparing these levels to a predetermined reference value, and ultimately providing prognostic information regarding survival time or recurrence risks based on the expression analysis. This inventive method can significantly aid medical professionals in making informed decisions about patient care.

Career Highlights: Throughout his career, Tabassome Simon has been associated with prominent research institutions, including the Institut National de la Santé et de la Recherche Médicale (INSERM) and Université Paris Descartes. His work in these esteemed organizations has not only showcased his expertise but also his unwavering commitment to advancing medical research and innovation.

Collaborations: Simon has worked alongside distinguished colleagues, including Ziad Mallat and Alain Tedgui. Their collaborative efforts have played a crucial role in enhancing the efficacy and applicability of Simon's innovations in the healthcare landscape.

Conclusion: Tabassome Simon exemplifies the essence of innovation in medicine, particularly in the realm of myocardial infarction prognosis. His patented method for predicting survival time by measuring BAFF levels underscores the importance of interdisciplinary collaboration and research in improving patient outcomes. As the medical community continues to advance, inventors like Simon remain at the forefront, tirelessly working to enhance the quality of care for individuals facing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…